Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Ping Dou

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Scientific Reports|January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBCLing Wu, Fanyan Meng, Lun Dong, et al.
Cancer Chemotherapy and Pharmacology|December 5, 2009
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell linesYing Wang, Arun K Rishi, Vineshkumar T Puliyappadamba, et al.
Cancer Biology & Medicine|May 23, 2022
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cellsLeyi Yao, Qian Zhao, Ding Yan, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 11, 2004
Green tea and tea polyphenols in cancer preventionDi Chen, Kenyon G Daniel, Deborah J Kuhn, et al.
The Journal of Investigative Dermatology|August 16, 2005
Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitorsJack L Arbiser, Xing-Cong Li, Chowdhury Fiaz Hossain, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
International Journal of Cancer|January 24, 2009
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivoHuanjie Yang, Ping Zhou, Hongbiao Huang, et al.
Journal of Cellular Physiology|April 27, 2007
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cellsXiaohua Li, Di Chen, Shuping Yin, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 17, 2014
Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer ChemotherapeuticsRichard T Arkwright, Rahul Deshmukh, Nikhil Adapa, et al.
Journal of Cellular Biochemistry|March 8, 2016
Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell LinesReda Saber Ibrahim Ahmed, Gang Liu, Andrea Renzetti, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Scientific Reports|January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBCLing Wu, Fanyan Meng, Lun Dong, et al.
Cancer Chemotherapy and Pharmacology|December 5, 2009
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell linesYing Wang, Arun K Rishi, Vineshkumar T Puliyappadamba, et al.
Cancer Biology & Medicine|May 23, 2022
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cellsLeyi Yao, Qian Zhao, Ding Yan, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 11, 2004
Green tea and tea polyphenols in cancer preventionDi Chen, Kenyon G Daniel, Deborah J Kuhn, et al.
The Journal of Investigative Dermatology|August 16, 2005
Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitorsJack L Arbiser, Xing-Cong Li, Chowdhury Fiaz Hossain, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
International Journal of Cancer|January 24, 2009
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivoHuanjie Yang, Ping Zhou, Hongbiao Huang, et al.
Journal of Cellular Physiology|April 27, 2007
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cellsXiaohua Li, Di Chen, Shuping Yin, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 17, 2014
Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer ChemotherapeuticsRichard T Arkwright, Rahul Deshmukh, Nikhil Adapa, et al.
Journal of Cellular Biochemistry|March 8, 2016
Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell LinesReda Saber Ibrahim Ahmed, Gang Liu, Andrea Renzetti, et al.
Pageof 23